OPKO Health Q4 2023 GAAP EPS $(0.09) Beats $(0.10) Estimate, Sales $181.90M Beat $177.53M Estimate
Author: Benzinga Newsdesk | February 27, 2024 05:24pm
OPKO Health (NASDAQ:
OPK) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 percent. The company reported quarterly sales of $181.90 million which beat the analyst consensus estimate of $177.53 million by 2.46 percent. This is a 1.89 percent decrease over sales of $185.40 million the same period last year.
Posted In: OPK